Primary sulphonylurea therapy in a newborn with transient neonatal diabetes attributable to a paternal uniparental disomy 6q24 (UPD6)

Diabetes Obes Metab. 2018 Feb;20(2):474-475. doi: 10.1111/dom.13085. Epub 2017 Oct 5.

Authors

Uta Neumann¹, Christoph Bührer², Oliver Blankenstein¹, Peter Kühnen¹, Klemens Raile^{1

3}

Affiliations

¹ Institute of Experimental Pediatric Endocrinology, Charité University Medicine Berlin, Berlin, Germany.
² Department of Neonatology, Charité University Medicine Berlin, Berlin, Germany.
³ Department of Pediatric Endocrinology and Diabetology, Charité University Medicine Berlin, Berlin, Germany.

PMID: 28817249
DOI: 10.1111/dom.13085

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Administration, Oral
Berlin
Blood Glucose / analysis
Diabetes Mellitus / blood
Diabetes Mellitus / drug therapy*
Diabetes Mellitus / genetics*
Dose-Response Relationship, Drug
Drug Monitoring
Fathers
Glyburide / administration & dosage
Glyburide / therapeutic use*
Humans
Hyperglycemia / prevention & control
Hypoglycemic Agents / administration & dosage
Hypoglycemic Agents / therapeutic use*
Infant, Low Birth Weight
Infant, Newborn
Infant, Newborn, Diseases / blood
Infant, Newborn, Diseases / drug therapy*
Infant, Newborn, Diseases / genetics*
Infant, Premature
Infant, Premature, Diseases / blood
Infant, Premature, Diseases / drug therapy*
Infant, Premature, Diseases / genetics*
Infusions, Intravenous
Insulin / administration & dosage
Insulin / therapeutic use
Male
Treatment Outcome
Uniparental Disomy*

Substances

Blood Glucose
Hypoglycemic Agents
Insulin
Glyburide

Supplementary concepts

Diabetes Mellitus, Transient Neonatal, 1